SPA
ATRC icon

Sherbrooke Park Advisers’s AtriCure ATRC Stock Holding History

Sherbrooke Park Advisers’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,792
Closed -$330K – 609
2024
Q4 		$330K Buy
+10,792
New +$347K 0.11% 356

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Sherbrooke Park Advisers's ATRC Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 10,792 shares — an estimated $330K sold.

Sherbrooke Park Advisers first reported a position in ATRC in Q4 2024 and held it in 1 quarter. The position peaked at $330K in Q4 2024. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 10,792 AtriCure shares in Q1 2025, an estimated $330K.
  • Sherbrooke Park Advisers first reported a position in AtriCure in Q4 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's AtriCure position peaked at $330K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.